Osmotic Activity

Human Serum Albumin

Ascites

Bacterial Infections

Burns

Cardiac Output, Low

Kidney Diseases

Peritonitis

Respiratory Distress Syndrome, Newborn

Respiratory Distress Syndrome

Shock

Hypovolemia

Hypoalbuminemia

<section class="Section" data-sectioncode="34089-3"><a name="ID_c5e4ca09-e258-44d0-cb01-ca67395bdc36"></a><a name="section-1"></a><p></p><h1>DESCRIPTION</h1><p class="First">Albumin (Human) 25%, USP (Albuked™ 25) is made from large pools of human venous plasma by the Cohn cold ethanol fractionation process. Part of the fractionation may be performed by another licensed manufacturer. It is prepared in accordance with the applicable requirements established by the U.S. Food and Drug Administration.</p><p>Albuked 25 is a 25% sterile solution of albumin in an aqueous diluent. The preparation is stabilized with 0.02 M sodium caprylate and 0.02 M acetyltryptophan. The aluminum content of the product is not more than 200 µg/L. The approximate sodium content of the product is 145 mEq/L. Albuked 25 is clear, slightly viscous, almost colorless to yellow, amber or green. It contains no preservative. Albuked 25 must be administered intravenously.</p><p>Each vial of Albuked 25 is heat-treated at 60°C for 10 hours against the possibility of transmitting the hepatitis viruses.</p><p>Additionally, the manufacturing process was investigated for its capacity to decrease the infectivity of an experimental agent of transmissible spongiform encephalopathy (TSE), considered as a model for the variant Creutzfeldt-Jakob disease (vCJD) and Creutzfeldt-Jakob disease (CJD) agents.<a href="#ID_d3c87e1e-6cf1-95da-887e-20aeb40e0bbc">(11-14)</a> The production steps from Pooled Plasma to Effluent IV-1 in the Albuked 25 manufacturing process have been shown to decrease TSE infectivity of that experimental model agent (a total of ≥7.0 logs). These studies provide reasonable assurance that low levels of vCJD/CJD agent infectivity, if present in the starting material, would be removed.</p></section>

Albuked

50 ML albumin human, USP 250 MG/ML Injection

100 ML albumin human, USP 250 MG/ML Injection

20 ML albumin human, USP 250 MG/ML Injection

50 ML albumin human, USP 250 MG/ML Injection [Albuked]

100 ML albumin human, USP 250 MG/ML Injection [Albuked]

20 ML albumin human, USP 250 MG/ML Injection [Albuked]

albumin human, USP

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event

Prescribing Information

Pharmacy List

How To Order Albuked 25%

Reimbursement Information

Coverage Authorization Request

Coverage Authorization Appeals

Enroll in Patient Savings Program

Instructions For Use